Skip to content

PMVP

PMV Pharmaceuticals, Inc.

NASDAQ · Healthcare · Biotechnology · US

$1.29
+4.03%
Ask drillr
0
Insider buys (3m)
0
Insider sells (3m)
$0.00
Net value (3m)
+15.6%
Price return (3m)
Form 4 filings
DateInsiderActivitySharesPrice
Jun 5, 2026LEVINE ARNOLD J · directorA-Award42,000$1.19
Jun 5, 2026Gallagher Carol Giltner · directorA-Award42,000$1.19
Jun 5, 2026FLOWERS KIRSTEN · directorA-Award42,000$1.19
Jun 5, 2026BAUM CHARLES M · directorA-Award42,000$1.19
Jun 5, 2026Stelzer Laurie · directorA-Award42,000$1.19
Mar 9, 2026Jalota Deepika · officer: Chief Development OfficerA-Award303,310$1.53
Mar 9, 2026Ticktin Robert · officer: General Counsel & COOA-Award319,270$1.53
Mar 9, 2026Carulli Michael · officer: Chief Financial OfficerA-Award240,000$1.53
Mar 9, 2026Mack David Henry · director, officer: President and CEOA-Award744,960$1.53
Oct 29, 2025Mack David Henry · director, officer: President and CEOM-Exempt220,643$1.37
Oct 27, 2025ORBIMED ADVISORS LLC · 10 percent ownerSale1,000,000$1.52
Sep 12, 2025ORBIMED ADVISORS LLC · 10 percent ownerSale500,000$1.80
Jul 3, 2025Mack David Henry · director, officer: President and CEOSale58,411$1.06
Jul 3, 2025Ticktin Robert · officer: General Counsel & COOSale23,151$1.06
Jul 3, 2025Jalota Deepika · officer: Chief Development OfficerSale33,065$1.06
Jul 3, 2025Carulli Michael · officer: Chief Financial OfficerSale28,249$1.06
Jun 9, 2025FLOWERS KIRSTEN · directorA-Award33,500$0.95
Jun 9, 2025BAUM CHARLES M · directorA-Award33,500$0.95
Jun 9, 2025Stelzer Laurie · directorA-Award33,500$0.95
Jun 9, 2025LEVINE ARNOLD J · directorA-Award33,500$0.95
Jun 9, 2025Heyman Richard A. · directorA-Award33,500$0.95
Jun 9, 2025Gallagher Carol Giltner · directorA-Award33,500$0.95
Mar 5, 2025Carulli Michael · officer: Chief Financial OfficerA-Award265,000$1.32
Mar 5, 2025Mack David Henry · director, officer: President and CEOA-Award800,000$1.32
Mar 5, 2025Jalota Deepika · officer: Chief Development OfficerA-Award300,000$1.32
Jan 22, 2025Mack David Henry · director, officer: President and CEOM-Exempt17,709$0.53
Jan 22, 2025Mack David Henry · director, officer: President and CEOM-Exempt91,750$0.53
Oct 3, 2024Carulli Michael · officer: Chief Financial OfficerA-Award40,805$1.48
Oct 3, 2024Mack David Henry · director, officer: President and CEOA-Award384,184$1.48
Oct 3, 2024Mack David Henry · director, officer: President and CEOA-Award330,000$1.48
Institutional positioning

13F filings over the trailing two quarters

New 15Increased 17Reduced 22Sold out 68
FilerActionSharesFiled
BML CAPITAL MANAGEMENT, LLCIncreased5,320,000May 6, 2026
TANG CAPITAL MANAGEMENT LLCReduced4,245,085May 15, 2026
SIO CAPITAL MANAGEMENT, LLCIncreased3,076,580May 14, 2026
ARROWMARK COLORADO HOLDINGS LLCReduced2,872,764May 15, 2026
EUCLIDEAN CAPITAL LLCUnchanged2,627,643May 15, 2026
EVERSEPT PARTNERS, LPNew Position2,348,360May 15, 2026
ACADIAN ASSET MANAGEMENT LLCIncreased2,215,894May 13, 2026
VANGUARD CAPITAL MANAGEMENT LLCNew Position1,974,906May 15, 2026
TWO SIGMA INVESTMENTS, LPIncreased1,884,530May 15, 2026
ADAGE CAPITAL PARTNERS GP, L.L.C.New Position1,860,000May 15, 2026
BLACKROCK, INC.Reduced874,374May 13, 2026
MORGAN STANLEYIncreased864,311May 15, 2026
STONEPINE CAPITAL MANAGEMENT, LLCReduced708,102May 14, 2026
LONGAEVA PARTNERS L.P.New Position552,027May 15, 2026
GEODE CAPITAL MANAGEMENT, LLCIncreased495,922May 15, 2026

Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Jun 5, 2026